These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18096431)

  • 1. Human CMV vaccine trials: what if CMV caused a rash?
    Adler SP
    J Clin Virol; 2008 Mar; 41(3):231-6. PubMed ID: 18096431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization to prevent congenital cytomegalovirus infection.
    Adler SP
    Br Med Bull; 2013; 107():57-68. PubMed ID: 23954939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for development and potential impact of a vaccine against congenital cytomegalovirus (CMV) infection.
    Schleiss MR
    J Pediatr; 2007 Dec; 151(6):564-70. PubMed ID: 18035130
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress in cytomegalovirus vaccine development.
    Schleiss M
    Herpes; 2005 Dec; 12(3):66-75. PubMed ID: 16393522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress toward an elusive goal: current status of cytomegalovirus vaccines.
    Schleiss MR; Heineman TC
    Expert Rev Vaccines; 2005 Jun; 4(3):381-406. PubMed ID: 16026251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization strategy for prevention of congenital cytomegalovirus infection.
    Pass RF
    Infect Agents Dis; 1996 Oct; 5(4):240-4. PubMed ID: 8884369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee.
    Arvin AM; Fast P; Myers M; Plotkin S; Rabinovich R;
    Clin Infect Dis; 2004 Jul; 39(2):233-9. PubMed ID: 15307033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of cytomegalovirus infection during a vaccine clinical trial in healthy young women: seroconversion and viral shedding.
    Zhang C; Buchanan H; Andrews W; Evans A; Pass RF
    J Clin Virol; 2006 Mar; 35(3):338-42. PubMed ID: 16388984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of cytomegalovirus infection during clinical trials of glycoprotein B vaccine.
    Zhang C; Pass RF
    Vaccine; 2004 Dec; 23(4):507-10. PubMed ID: 15530699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling immunization strategies with cytomegalovirus vaccine candidates.
    Azevedo RS; Amaku M
    Epidemiol Infect; 2011 Dec; 139(12):1818-26. PubMed ID: 21396147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of vaccine strategies against congenital CMV infection in the guinea pig model.
    Schleiss MR
    J Clin Virol; 2008 Mar; 41(3):224-30. PubMed ID: 18060834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of routine vaccination of adolescent females against cytomegalovirus.
    Dempsey AF; Pangborn HM; Prosser LA
    Vaccine; 2012 Jun; 30(27):4060-6. PubMed ID: 22525796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMV vaccine trial endpoints.
    Griffiths PD
    J Clin Virol; 2009 Dec; 46 Suppl 4():S64-7. PubMed ID: 19879802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital cytomegalovirus infection.
    Syggelou A; Iacovidou N; Kloudas S; Christoni Z; Papaevangelou V
    Ann N Y Acad Sci; 2010 Sep; 1205():144-7. PubMed ID: 20840266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus vaccines: current status.
    Starr SE
    Infect Agents Dis; 1992 Jun; 1(3):146-8. PubMed ID: 1365538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward developing a cytomegalovirus vaccine.
    Marshall GS; Plotkin SA
    Infect Dis Clin North Am; 1990 Jun; 4(2):283-98. PubMed ID: 2161034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine strategies against human cytomegalovirus infection.
    Zhong J; Khanna R
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):449-59. PubMed ID: 17547509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical and intellectual development in children with asymptomatic congenital cytomegalovirus infection: a longitudinal cohort study in Qinba mountain area, China.
    Zhang XW; Li F; Yu XW; Shi XW; Shi J; Zhang JP
    J Clin Virol; 2007 Nov; 40(3):180-5. PubMed ID: 17919973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine.
    Schleiss MR; Stroup G; Pogorzelski K; McGregor A
    Vaccine; 2006 Sep; 24(37-39):6175-86. PubMed ID: 16879902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection.
    Bourne N; Schleiss MR; Bravo FJ; Bernstein DI
    J Infect Dis; 2001 Jan; 183(1):59-64. PubMed ID: 11087203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.